Publications by the researcher in collaboration with Sergio Manzano Fernandez (42)

2022

  1. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

    European Journal of Internal Medicine, Vol. 99, pp. 45-56

  2. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC Medicine, Vol. 20, Núm. 1

  3. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Europace, Vol. 24, Núm. 5, pp. 721-728

  4. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

  5. Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 6

2021

  1. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    BMC Medicine, Vol. 19, Núm. 1

2016

  1. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non–ST-Segment Elevation Acute Coronary Syndrome

    Clinical Cardiology, Vol. 39, Núm. 9, pp. 507-515

2015

  1. Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 68, Núm. 6, pp. 497-504

  2. Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome

    European Journal of Clinical Investigation, Vol. 45, Núm. 4, pp. 385-393

  3. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation

    European Journal of Clinical Investigation, Vol. 45, Núm. 9, pp. 899-905

2014

  1. Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients

    International Journal of Clinical Practice, Vol. 68, Núm. 3, pp. 294-303

  2. Methods of kidney function assessment in non-valvular atrial fibrillation in the era of new oral anticoagulants

    European Journal of Internal Medicine

  3. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation

    Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 781-788

  4. Red cell distribution width and coronary artery disease. Response

    Revista Espanola de Cardiologia

  5. Usefulness of N- Terminal pro-B- Type natriuretic peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation

    Stroke, Vol. 45, Núm. 3, pp. 696-701

  6. ¿Por qué debemos estratificar el riesgo hemorrágico junto con el isquémico en el síndrome coronario agudo?

    Revista Espanola de Cardiologia Suplementos, Vol. 14, Núm. S1, pp. 10-17

2013

  1. Beta-trace protein and cystatin C as predictors of major bleeding in non-ST-segment elevation acute coronary syndrome

    Circulation Journal, Vol. 77, Núm. 8, pp. 2088-2096

  2. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

    Thrombosis and Haemostasis, Vol. 109, Núm. 5, pp. 956-960

  3. Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST

    Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 185-192

  4. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Age and Ageing, Vol. 42, Núm. 1, pp. 70-75